Related Experiment Video
Updated: Oct 18, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1-RIPK3-Dependent Pathway in Mice
Penglong Wu1,2, Mingqi Cai1, Jinbao Liu2
1Division of Basic Biomedical Sciences, University of South Dakota Sanford School of Medicine, Vermillion, SD, United States.
Insights
Excessive beta-adrenergic stimulation causes heart damage through necroptosis, a regulated cell death pathway involving RIPK1 and RIPK3. These proteins are potential therapeutic targets for catecholamine surge-related cardiac injury.
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Molecular Cardiology
Background:
- Catecholamine surges and excessive beta-adrenergic stimulation are linked to various diseases.
- Excessive beta-adrenergic stimulation can cause cardiomyocyte necrosis, but the mechanism is unclear.
- Necroptosis, a regulated necrosis pathway, is implicated in heart failure, but its role in beta-adrenergic stimulation-induced cardiac injury is unknown.
Purpose of the Study:
- To investigate if excessive beta-adrenergic stimulation-induced cardiac injury involves necroptosis.
- To elucidate the role of RIPK1 and RIPK3 in this process.
Main Methods:
- Adult mice received daily isoproterenol (ISO) injections or saline.
- Cardiac injury was assessed using Evans blue dye (EBD) uptake.
- Myocardial protein levels of RIPK1, RIPK3, and MLKL phosphorylation were measured.
- Experiments were conducted in wild-type (WT) and RIPK3 knockout mice.
- Mice were treated with a RIPK1 inhibitor (necrostatin-1).
Main Results:
- ISO treatment significantly increased cardiac EBD uptake and levels of RIPK1, RIPK3, and phosphorylated MLKL in WT mice.
- RIPK3 deficiency markedly reduced ISO-induced cardiac injury.
- Necrostatin-1 inhibited RIPK3 and MLKL phosphorylation and attenuated cardiac injury in WT mice, but not in RIPK3 knockout mice.
Conclusions:
- Cardiomyocyte necrosis from excessive beta-adrenergic stimulation is largely mediated by necroptosis.
- This necroptosis involves a RIPK1-RIPK3-dependent pathway.
- RIPK1 and RIPK3 are identified as potential therapeutic targets for conditions involving catecholamine surges.
Abstract:
Background: Catecholamine surges and resultant excessive β-adrenergic stimulation occur in a broad spectrum of diseases. Excessive β-adrenergic stimulation causes cardiomyocyte necrosis, but the underlying mechanism remains obscure. Necroptosis, a major form of regulated necrosis mediated by RIPK3-centered pathways, is implicated in heart failure; however, it remains unknown whether excessive β-adrenergic stimulation-induced cardiac injury involves necroptosis. Hence, we conducted the present study to address these critical gaps. Methods and Results: Two consecutive daily injections of isoproterenol (ISO; 85 mg/kg, s.c.) or saline were administered to adult mixed-sex mice. At 24 h after the second ISO injection, cardiac area with Evans blue dye (EBD) uptake and myocardial protein levels of CD45, RIPK1, Ser166-phosphorylated RIPK1, RIPK3, and Ser345-phosphorylated MLKL (p-MLKL) were significantly greater, while Ser321-phosphorylated RIPK1 was significantly lower, in the ISO-treated than in saline-treated wild-type (WT) mice. The ISO-induced increase of EBD uptake was markedly less in RIPK3 -/- mice compared with WT mice (p = 0.016). Pretreatment with the RIPK1-selective inhibitor necrostatin-1 diminished ISO-induced increases in RIPK3 and p-MLKL in WT mice and significantly attenuated ISO-induced increases of EBD uptake in WT but not RIPK3-/- mice. Conclusions: A large proportion of cardiomyocyte necrosis induced by excessive β-adrenergic stimulation belongs to necroptosis and is mediated by a RIPK1-RIPK3-dependent pathway, identifying RIPK1 and RIPK3 as potential therapeutic targets for catecholamine surges.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Myocarditis I: Introduction

